HomeBIOVF • OTCMKTS
add
Swedish Orphan Biovitrum AB (publ)
Previous close
$25.00
Day range
$22.87 - $23.74
Year range
$18.35 - $27.79
Market cap
99.50B SEK
Avg Volume
54.00
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Dec 2023info | Y/Y change |
|---|---|---|
Revenue | 6.84B | 14.24% |
Operating expense | 3.61B | 32.10% |
Net income | 1.03B | -25.97% |
Net profit margin | 14.99 | -35.22% |
Earnings per share | 3.18 | -31.47% |
EBITDA | 2.66B | 21.27% |
Effective tax rate | 17.12% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Dec 2023info | Y/Y change |
|---|---|---|
Cash and short-term investments | 904.00M | -33.58% |
Total assets | 74.03B | 41.01% |
Total liabilities | 40.16B | 54.63% |
Total equity | 33.87B | — |
Shares outstanding | 339.76M | — |
Price to book | 0.25 | — |
Return on assets | 6.26% | — |
Return on capital | 8.53% | — |
Cash Flow
Net change in cash
| (SEK) | Dec 2023info | Y/Y change |
|---|---|---|
Net income | 1.03B | -25.97% |
Cash from operations | 1.07B | -43.37% |
Cash from investing | -458.00M | -626.98% |
Cash from financing | -358.00M | 53.57% |
Net change in cash | 226.00M | -78.94% |
Free cash flow | 245.75M | -81.58% |
About
Swedish Orphan Biovitrum AB is an international biopharmaceutical company dedicated to treatments in the areas of haematology, immunology and specialty care, based in Stockholm, Sweden.
In 2020 it had a revenue of SEK 15.261 billion and 1,509 employees. Wikipedia
Founded
1939
Website
Employees
1,772
